Boyanova, L., Nikolov, R., Lazarova, E., Gergova, G., Katsarov, N., Kamburov, V., Spassova, Z., Derejian, S., Jelev, C., Mitov, I., Krastev, Z.
Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years
(2006) Journal of Medical Microbiology, 55 (1), pp. 65-68. Cited 11 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-29744455988&partnerID=40&md5=2bc0a623a2828fa944e7549091f0dbf1
DOCUMENT TYPE: Article
SOURCE: Scopus
Agudo, S., Alarcón, T., Cibrelus, L., Urruzuno, P., Martínez, M.J., López-Brea, M.
High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children
(2009) Revista Espanola de Quimioterapia, 22 (2), pp. 88-92. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-70349563749&partnerID=40&md5=247f7eff052e3700b54531520231c5d1
DOCUMENT TYPE: Article
SOURCE: Scopus
Chang, W.-L., Sheu, B.-S., Cheng, H.-C., Yang, Y.-J., Yang, H.-B., Wu, J.-J.
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan
(2009) Journal of Gastroenterology and Hepatology, 24 (7), pp. 1230-1235. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-68749088899&partnerID=40&md5=a901aa9dcf3287c7d96ecf6bcc825e35
DOCUMENT TYPE: Article
SOURCE: Scopus
Karczewska, E., Wojtas, I., Budak, A.
Prevalence of Helicobacter pylori primary resistance to antimicrobial agents in Poland and around the world [Wystȩpowanie pierwotnej oporności Helicobacter pylori na leki przeciwbakteryjne w polsce i na świecie]
(2009) Postepy Mikrobiologii, 48 (1), pp. 31-41.
http://www.scopus.com/inward/record.url?eid=2-s2.0-66649124292&partnerID=40&md5=4442e41c192b8139d352198edb8238c9
DOCUMENT TYPE: Review
SOURCE: Scopus
Shashidhar, H., Flomenhoft, D., Tolia, V.
Helicobacter pylori and beyond: Pediatric peptic ulcer disease
(2009) Therapy, 6 (1), pp. 65-73. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-69849113782&partnerID=40&md5=cd24aacc6f848feacb279a7f1eaa78d8
DOCUMENT TYPE: Review
SOURCE: Scopus
Machado, R.S., Da Silva, M.R., Viriato, A.
Furazolidone, tetracycline and omeprazole: A low-cost alternative for Helicobacter pylori eradication in children
(2008) Jornal de Pediatria, 84 (2), pp. 160-165. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-43049118637&partnerID=40&md5=d04de0f20d722ecdd47edf60811ae6b4
DOCUMENT TYPE: Article
SOURCE: Scopus
Sabbi, T., De Angelis, P., Dall'Oglio, L.
Helicobacter pylori infection in children: Management and pharmacotherapy
(2008) Expert Opinion on Pharmacotherapy, 9 (4), pp. 577-585. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-40649096604&partnerID=40&md5=dc141d02941b899cf32a022e97ef412f
DOCUMENT TYPE: Review
SOURCE: Scopus
Kalach, N., Serhal, L., Asmar, E., Campeotto, F., Bergeret, M., Dehecq, E., Spyckerelle, C., Charkaluk, M.-L., Decoster, A., Dupont, C., Raymond, J.
Helicobacter pylori primary resistant strains over 11 years in French children
(2007) Diagnostic Microbiology and Infectious Disease, 59 (2), pp. 217-222. Cited 10 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-34748851971&partnerID=40&md5=433fca8726037b5299cfd0202a7f3958
DOCUMENT TYPE: Article
SOURCE: Scopus
Vakil, N., Megraud, F.
Eradication Therapy for Helicobacter pylori
(2007) Gastroenterology, 133 (3), pp. 985-1001. Cited 42 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-34548507671&partnerID=40&md5=675c478d7473ecf59a5173e11d377214
DOCUMENT TYPE: Review
SOURCE: Scopus
Dorta, G., Viani, F., Vouillamoz, D., Jornod, P., Kessler-Brondolo, V., Nichita, C.
Peptic diseases [Maladies peptiques]
(2007) Revue Medicale Suisse, 3 (95), pp. 192-200.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33846857966&partnerID=40&md5=f9d6f6deba842679194df5056435b018
DOCUMENT TYPE: Review
SOURCE: Scopus
Horvitz, G., Gold, B.D.
Gastroduodenal diseases of childhood
(2006) Current Opinion in Gastroenterology, 22 (6), pp. 632-640. Cited 6 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33750287625&partnerID=40&md5=ccb3a773aee688c452141abdfc3e94e0
DOCUMENT TYPE: Review
SOURCE: Scopus
Chisholm, S.A., Owen, R.J.
From nobel to no cure: A case for monitoring antibiotic resistance in the gastric pathogen Helicobacter pylori
(2006) Expert Review of Anti-Infective Therapy, 4 (3), pp. 349-351.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33745208232&partnerID=40&md5=04a043d90d49d28cc958779c8b7e6941
DOCUMENT TYPE: Editorial
SOURCE: Scopus
Krastev, Z., Koltchakov, V., Tomova, R., Deredjian, S., Alexiev, A., Popov, D., Tomov, B., Koten, J.-W., Jacobs, J., Den Otter, W.
Locoregional IL-2 low dose applications for gastrointestinal tumors
(2005) World Journal of Gastroenterology, 11 (35), pp. 5525-5529. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-28044433404&partnerID=40&md5=3890aab5973d206b34687a948f581ac4
DOCUMENT TYPE: Article
SOURCE: Scopus
Shaker, M.A., Younes, H.M.
Interleukin-2: Evaluation of routes of administration and current delivery systems in cancer therapy
(2009) Journal of Pharmaceutical Sciences, 98 (7), pp. 2268-2298. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-67650165335&partnerID=40&md5=2b76c1b678b4d2e87cae19b90a2c101b
DOCUMENT TYPE: Review
SOURCE: Scopus
Caporale, A., Brescia, A., Galati, G., Castelli, M., Saputo, S., Terrenato, I., Cucina, A., Liverani, A., Gasparrini, M., Ciardi, A., Scarpini, M., Cosenza, U.M.
Locoregional IL-2 therapy in the treatment of colon cancer. Cell-induced lesions of a murine model
(2007) Anticancer Research, 27 (2), pp. 985-989. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-34247162394&partnerID=40&md5=fec05dd12dc6d48533877b78f9751ad2
DOCUMENT TYPE: Article
SOURCE: Scopus
Boyanova, L., Gergova, G., Nikolov, R., Derejian, S., Lazarova, E., Katsarov, N., Mitov, I., Krastev, Z.
Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods
(2005) Journal of Medical Microbiology, 54 (5), pp. 481-483. Cited 14 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-18044386342&partnerID=40&md5=46e3533bba6c14c5ce09e6354ac0af69
DOCUMENT TYPE: Article
SOURCE: Scopus
Nolkemper, S., Reichling, J., Sensch, K.H., Schnitzler, P.
Mechanism of herpes simplex virus type 2 suppression by propolis extracts
(2010) Phytomedicine, 17 (2), pp. 132-138. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-73449120684&partnerID=40&md5=d4091c877d7bfcab1f07daf25e00b242
DOCUMENT TYPE: Article
SOURCE: Scopus
Schnitzler, P., Neuner, A., Nolkemper, S., Zundel, C., Nowack, H., Sensch, K.H., Reichling, J.
Antiviral activity and mode of action of propolis extracts and selected compounds
(2010) Phytotherapy Research, 24 (SUPPL. 1), pp. S20-S28. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-75749151225&partnerID=40&md5=aa5369445bceeb2df164af312b45b1bc
DOCUMENT TYPE: Article
SOURCE: Scopus
Campana, R., Patrone, V., Franzini, I.T.M., Diamantini, G., Vittoria, E., Baffone, W.
Antimicrobial activity of two propolis samples against human campylobacter jejuni
(2009) Journal of Medicinal Food, 12 (5), pp. 1050-1056.
http://www.scopus.com/inward/record.url?eid=2-s2.0-70350492509&partnerID=40&md5=80656a9b7f782e305849f6844b1ad137
DOCUMENT TYPE: Article
SOURCE: Scopus
Abd-El-Rhman, A.M.M.
Antagonism of Aeromonas hydrophila by propolis and its effect on the performance of Nile tilapia, Oreochromis niloticus
(2009) Fish and Shellfish Immunology, 27 (3), pp. 454-459.
http://www.scopus.com/inward/record.url?eid=2-s2.0-68949145934&partnerID=40&md5=e4058ee0de02e3f69098ae14b65aea69
DOCUMENT TYPE: Article
SOURCE: Scopus
Liu, Q., Yu, J., Yan, J., Qi, X., Liu, C., Jin, H.
Antagonism and action mechanism of antifungal metabolites from streptomyces rimosus MY02
(2009) Journal of Phytopathology, 157 (5), pp. 306-310.
http://www.scopus.com/inward/record.url?eid=2-s2.0-64049109687&partnerID=40&md5=dd80dd31a07afebeb61ff7d3108a136f
DOCUMENT TYPE: Article
SOURCE: Scopus
Ghedira, K., Goetz, P., Le Jeune, R.
Practical Materia Medica: Propolis [Matière médicale pratique: Propolis]
(2009) Phytotherapie, 7 (2), pp. 100-105.
http://www.scopus.com/inward/record.url?eid=2-s2.0-65649097301&partnerID=40&md5=34c82c92543d56f4153b25e024223341
DOCUMENT TYPE: Article
SOURCE: Scopus
Jain, R., Saxena, U., Rathore, K., Jain, S.C.
Bioactivities of polyphenolics from the roots of Bauhinia racemosa
(2008) Archives of Pharmacal Research, 31 (12), pp. 1525-1529.
http://www.scopus.com/inward/record.url?eid=2-s2.0-58449135798&partnerID=40&md5=0269ec6aadcc712883971251da221fc6
DOCUMENT TYPE: Article
SOURCE: Scopus
Seidel, V., Peyfoon, E., Watson, D.G., Fearnley, J.
Comparative study of the antibacterial activity of propolis from different geographical and climatic zones
(2008) Phytotherapy Research, 22 (9), pp. 1256-1263. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-52649090230&partnerID=40&md5=822dae80d825f2b0909f8facd6407b27
DOCUMENT TYPE: Article
SOURCE: Scopus
Nirala, S.K., Bhadauria, M.
Propolis reverses acetaminophen induced acute hepatorenal alterations: A biochemical and histopathological approach
(2008) Archives of Pharmacal Research, 31 (4), pp. 451-461. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-43049097150&partnerID=40&md5=5d1d7a58534eccb3e7dade2990b2b49f
DOCUMENT TYPE: Article
SOURCE: Scopus
Bergamaschi, A., Magrini, A., Pietroiusti, A.
Recent advances in the treatment of Helicobacter pylori infection
(2007) Recent Patents on Anti-Infective Drug Discovery, 2 (3), pp. 197-205. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-36749002870&partnerID=40&md5=76b33f2b5b6a684d32ab3412b8bb02ba
DOCUMENT TYPE: Article
SOURCE: Scopus
Vaz Coelho, L.G., Ferreira Bastos, E.M.A., Resende, C.C., Paula E Silva, C.M., Fernandes Sanches, B.S., De Castro, F.J., Moretzsohn, L.D., Dos Santos Vieira, W.L., Trindade, O.R.
Brazilian green propolis on Helicobacter pylori infection. A pilot clinical study
(2007) Helicobacter, 12 (5), pp. 572-574. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-34548153045&partnerID=40&md5=754c72ffcd428629681a163f0093ebdc
DOCUMENT TYPE: Article
SOURCE: Scopus
Wolle, K., Malfertheiner, P.
Treatment of Helicobacter pylori
(2007) Best Practice and Research in Clinical Gastroenterology, 21 (2), pp. 315-324. Cited 19 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33947276400&partnerID=40&md5=4ef855a536716a6092ca9c5fda060ca9
DOCUMENT TYPE: Article
SOURCE: Scopus
Zekovic̀, Z., Lepojević, Ž., Mujić, I.
SFE of PMT mixture by supercritical CO2
(2006) CHISA 2006 - 17th International Congress of Chemical and Process Engineering, .
http://www.scopus.com/inward/record.url?eid=2-s2.0-34748836457&partnerID=40&md5=1498bd806c40d7e06aeeb07a93ed5484
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus
Di Mario, F., Cavallaro, L.G., Scarpignato, C.
'Rescue' therapies for the management of Helicobacter pylori infection
(2006) Digestive Diseases, 24 (1-2), pp. 113-130. Cited 21 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33644537268&partnerID=40&md5=e59ac63b279c5cf251929295d6a93649
DOCUMENT TYPE: Review
SOURCE: Scopus
Boyanova, L., Gergova, G., Spassova, Z., Koumanova, R., Yaneva, P., Mitov, I., Derejian, S., Krastev, Z.
Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases
(2004) Diagnostic Microbiology and Infectious Disease, 49 (1), pp. 71-74. Cited 14 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-2342600180&partnerID=40&md5=d9de6b35ad6f8ee285c779122d41b535
DOCUMENT TYPE: Article
SOURCE: Scopus
Palyada, K., Sun, Y.-Q., Flint, A., Butcher, J., Naikare, H., Stintzi, A.
Characterization of the oxidative stress stimulon and PerR regulon of Campylobacter jejuni
(2009) BMC Genomics, 10, art. no. 1471, p. 481.
http://www.scopus.com/inward/record.url?eid=2-s2.0-70549097051&partnerID=40&md5=5bc79c2cea1756595c0a1d55df472407
DOCUMENT TYPE: Article
SOURCE: Scopus
Gradel, K.O., Nielsen, H.L., Schønheyder, H.C., Ejlertsen, T., Kristensen, B., Nielsen, H.
Increased Short- and Long-Term Risk of Inflammatory Bowel Disease After Salmonella or Campylobacter Gastroenteritis
(2009) Gastroenterology, 137 (2), pp. 495-501. Cited 15 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-67650973314&partnerID=40&md5=650abd703f12e0e908ed8395da87f427
DOCUMENT TYPE: Article
SOURCE: Scopus
Tambur, Z., Miljkovic-Selimovic, B., Bokonjic, D., Kulisic, Z.
Susceptibility of Campylobacter jejuni and Campylobacter coli isolated from animals and humans to ciprofloxacin
(2009) Polish Journal of Veterinary Sciences, 12 (2), pp. 269-273.
http://www.scopus.com/inward/record.url?eid=2-s2.0-67650686659&partnerID=40&md5=690d7da5a0f8c1d3e59afb376b6f3ab1
DOCUMENT TYPE: Article
SOURCE: Scopus
Navarro-Llavat, M., Domènech, E., Bernal, I., Sánchez-Delgado, J., Manterola, J.M., Garcia-Planella, E., Mañosa, M., Cabré, E., Gassull, M.A.
Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients
(2009) Digestion, 80 (1), pp. 25-29. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-65549084451&partnerID=40&md5=148b73c93109785ff11a48fb5b50a5d6
DOCUMENT TYPE: Article
SOURCE: Scopus
Rodríguez, N., Real, B.D., Cruz Ortiz, M., Sarabia, L.A., Herrero, A.
Usefulness of parallel factor analysis to handle the matrix effect in the fluorescence determination of tetracycline in whey milk
(2009) Analytica Chimica Acta, 632 (1), pp. 42-51. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-57649094376&partnerID=40&md5=f609b217837ed7afc46550fc236ba895
DOCUMENT TYPE: Article
SOURCE: Scopus
Tambur, Z., Miljković-Selimović, B., Bokonjić, D.
Determination of sensitivity to antibiotics of Campilobacter jejuni and Campilobacter coli isolated from human feces [Ispitivanje osetljivosti na antibiotike Campylobacter jejuni i C. coli izolovanih iz ljudi]
(2009) Vojnosanitetski Pregled, 66 (1), pp. 49-52.
http://www.scopus.com/inward/record.url?eid=2-s2.0-60749099767&partnerID=40&md5=3eac042f20b8031bb2406698b218be5b
DOCUMENT TYPE: Article
SOURCE: Scopus
Wine, E., Chan, V.L., Sherman, P.M.
Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion
(2008) Pediatric Research, 64 (6), pp. 599-604. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-57849138461&partnerID=40&md5=21c65af8ee33f77757244bf0a391aca3
DOCUMENT TYPE: Article
SOURCE: Scopus
Gellynck, X., Messens, W., Halet, D., Gruspeerdt, K., Hartnett, E., Viaene, J.
Economics of reducing Campylobacter at different levels within the Belgian poultry meat chain
(2008) Journal of Food Protection, 71 (3), pp. 479-485. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-40949121610&partnerID=40&md5=52549f4cf967e7b5480c1a09017d0494
DOCUMENT TYPE: Article
SOURCE: Scopus
McGill, K., Cowley, D., Moran, L., Scates, P., O'Leary, A., Madden, R.H., Carroll, C., McNamara, E., Moore, J.E., Fanning, S., Collins, J.D., Whyte, P.
Antibiotic resistance of retail food and human Campylobacter isolates on the island of Ireland from 2001-2002
(2006) Epidemiology and Infection, 134 (6), pp. 1282-1291. Cited 6 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33750287605&partnerID=40&md5=bb846c6e8171ea41c46cf0d189294422
DOCUMENT TYPE: Article
SOURCE: Scopus
Cagliero, C., Mouline, C., Cloeckaert, A., Payot, S.
Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli
(2006) Antimicrobial Agents and Chemotherapy, 50 (11), pp. 3893-3896. Cited 14 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33750577739&partnerID=40&md5=3aa807257d661a0b5691057a1e47bd18
DOCUMENT TYPE: Article
SOURCE: Scopus
Gibreel, A., Taylor, D.E.
Macrolide resistance in Campylobacter jejuni and Campylobacter coli
(2006) Journal of Antimicrobial Chemotherapy, 58 (2), pp. 243-255. Cited 32 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33748057492&partnerID=40&md5=d10419909681535f9d2d28e79c275700
DOCUMENT TYPE: Review
SOURCE: Scopus
Cagliero, C., Cloix, L., Cloeckaert, A., Payot, S.
High genetic variation in the multidrug transporter cmeB gene in Campylobacter jejuni and Campylobacter coli
(2006) Journal of Antimicrobial Chemotherapy, 58 (1), pp. 168-172. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33748066638&partnerID=40&md5=3b378e398536bab94091ec1dd4c311cc
DOCUMENT TYPE: Article
SOURCE: Scopus
Rodríguez-Avial, I., Rodríguez-Avial, C., López, O., Culebras, E., Picazo, J.J.
In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates
(2006) International Journal of Antimicrobial Agents, 27 (4), pp. 303-306. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33645989201&partnerID=40&md5=a7d0be297c3206c8142a7248375e97af
DOCUMENT TYPE: Article
SOURCE: Scopus
Cagliero, C., Mouline, C., Payot, S., Cloeckaert, A.
Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli
(2005) Journal of Antimicrobial Chemotherapy, 56 (5), pp. 948-950. Cited 21 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-27744597006&partnerID=40&md5=82f512345a901eefd87946aa4239bebb
DOCUMENT TYPE: Article
SOURCE: Scopus
Boyanova, L., Katsarov, N., Gergova, G., Nikolov, R., Derejian, S., Spassova, Z., Mitov, I., Krastev, Z.
Helicobacter pylori infection in elderly Bulgarian patients [3]
(2003) Journal of Medical Microbiology, 52 (12), pp. 1131-1133. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-1542644972&partnerID=40&md5=5642cf861eea4d280790d6cc6afb0c65
DOCUMENT TYPE: Letter
SOURCE: Scopus
Giles, H., Hajek, C., Stoitsova, T., Choi, C.W. Intergenerational communication satisfaction and age boundaries in Bulgaria and the United States, Journal of Cross-Cultural Gerontology (2010) 25 (2), pp. 133-147.
Krastev, Z., Koltchakov, V., Popov, D., Alexiev, A., Koten, J.W., Den Otter, W.
A case of hepatocellular carcinoma (HCC): Treatment with local application of alcohol and interleukin 2 (IL-2)
(2003) Hepato-Gastroenterology, 50 (53), pp. 1647-1649. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0141650696&partnerID=40&md5=eecc03acbde8c8fb2c3af6ae3e18d422
DOCUMENT TYPE: Article
SOURCE: Scopus
Tomova, R., Antonov, K., Ivanova, A., Jacobs, J.L., Koten, J.W., Den Otter, W., Krastev, Z.
Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: Case report
(2009) Anticancer Research, 29 (12), pp. 5241-5244.
http://www.scopus.com/inward/record.url?eid=2-s2.0-75149160469&partnerID=40&md5=4ad0637e4122af4139c4911f4f0a7214
DOCUMENT TYPE: Article
SOURCE: Scopus
Wagner, K., Schulz, P., Scholz, A., Wiedenmann, B., Menrad, A.
The targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer
(2008) Clinical Cancer Research, 14 (15), p. 4951. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-51049100187&partnerID=40&md5=ef94a2aa453486596e60887da22cb4f4
DOCUMENT TYPE: Article
SOURCE: Scopus
Krastev, Z., Koltchakov, V., Tomov, B., Koten, J.W.
Non-melanoma and non-renal cell carcinoma malignancies treated with interleukin-2
(2003) Hepato-Gastroenterology, 50 (52), pp. 1006-1016. Cited 8 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-0038000713&partnerID=40&md5=5349f3af905f50ed013ea48e27813c44
DOCUMENT TYPE: Review
SOURCE: Scopus
Tomova, R., Antonov, K., Ivanova, A., Jacobs, J.L., Koten, J.W., Den Otter, W., Krastev, Z.
Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: Case report
(2009) Anticancer Research, 29 (12), pp. 5241-5244.
http://www.scopus.com/inward/record.url?eid=2-s2.0-75149160469&partnerID=40&md5=4ad0637e4122af4139c4911f4f0a7214
DOCUMENT TYPE: Article
SOURCE: Scopus
Nobili, C., Degrate, L., Caprotti, R., Franciosi, C., Leone, B.E., Trezzi, R., Romano, F., Uggeri, F., Uggeri, F.
Prolonged survival of a patient affected by pancreatic adenocarcinoma with massive lymphocyte and dendritic cell infiltration after interleukin-2 immunotherapy Report of a case
(2008) Tumori, 94 (3), pp. 426-430. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-48249097922&partnerID=40&md5=e291ebb25974929d9c50b427639e34f9
DOCUMENT TYPE: Article
SOURCE: Scopus
Dummer, R., Rochlitz, C., Velu, T., Acres, B., Limacher, J.-M., Bleuzen, P., Lacoste, G., Slos, P., Romero, P., Urosevic, M.
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma
(2008) Molecular Therapy, 16 (5), pp. 985-994. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-42549165017&partnerID=40&md5=def9ccd79c7b8c8224da430ad446784c
DOCUMENT TYPE: Article
SOURCE: Scopus
Tomova, R., Pomakov, J., Jacobs, J.J.L., Adjarov, D., Popova, S., Altankova, I., Den Otter, W., Krastev, Z.
Changes in cytokine profile during local IL-2 therapy in cancer patients
(2006) Anticancer Research, 26 (3 A), pp. 2037-2047. Cited 5 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33745590423&partnerID=40&md5=227c03fb1f27ddcccc6ef9fb293baad5
DOCUMENT TYPE: Article
SOURCE: Scopus
Steppan, S., Eckart, M.R., Bajsarowicz, K., Sternberg, L.R., Greve, J.M., Cassell, D.J.
Reduced secondary cytokine induction by BAY 50-4798, a high-affinity receptor-specific interleukin-2 analog
(2006) Journal of Interferon and Cytokine Research, 26 (3), pp. 171-178. Cited 6 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33645413614&partnerID=40&md5=a2fb829d1f424e90cdef9e5c6cb5cd10
DOCUMENT TYPE: Article
SOURCE: Scopus
Grande, C., Firvida, J.L., Navas, V., Casal, J.
Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma
(2006) Anti-Cancer Drugs, 17 (1), pp. 1-12. Cited 25 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-33646103420&partnerID=40&md5=e10c3b3b9f769fa86f878be956796f41
DOCUMENT TYPE: Review
SOURCE: Scopus
Schwinger, W., Klass, V., Benesch, M., Lackner, H., Dornbusch, H.J., Sovinz, P., Moser, A., Schwantzer, G., Urban, C.
Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients
(2005) Annals of Oncology, 16 (7), pp. 1199-1206. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-25444441051&partnerID=40&md5=71cba179f7eb3fccbde2563f157e9454
DOCUMENT TYPE: Article
SOURCE: Scopus
Zhang, W.-Y., Yip, T.-C., Kwok, C.-S.
Rapid purification of a new humanized single-chain Fv antibody/human interleukin-2 fusion protein reactive against HER2 receptor
(2004) Acta Biochimica et Biophysica Sinica, 36 (10), pp. 707-712.
http://www.scopus.com/inward/record.url?eid=2-s2.0-10044241851&partnerID=40&md5=285b6ac613cb2c3cc4efe206c3d5bdb6
DOCUMENT TYPE: Article
SOURCE: Scopus
Сподели с приятели: |